LORIUM · 5 mg LYOPHILISED VIALThymosin Alpha-1
Thymosin Alpha 1 is a premium synthetic 28-amino-acid peptide analogue engineered to act as an elite cellular sensor and master immunomodulator. By activating critical Toll-like receptors (TLR-2/TLR-9) and downstream signaling pathways, this advanced protocol safely drives T-cell maturation and NK-cell cytotoxicity to provide a strong dual-action shield against cellular stress and immune decline.
Researched effects
Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.
T-Cell Maturation
Actively increases absolute CD4+ and CD8+ cell counts and functionality.
Systemic Antiviral Defense
Studied to support deep viral suppression and cellular immune recovery.
Immune Homeostasis
Balances cytokine production while lowering pro-inflammatory mediators.
Enhanced Vaccine Response
Significantly boosts overall immunogenicity and memory response.
Cellular Defense
Strongly enhances natural killer (NK) cell cytotoxicity and activation.
Genomic Integrity
Triggers tumor cell apoptosis through precise PTEN-mediated pathways.
Dendritic Cell Priming
Sharpens antigen presentation for immediate systemic immune readiness.
Specifications
Clinical references
- Liu, Y., et al. (2020). Thymosin Alpha 1: Comprehensive Review of Literature. WJG, 26(47).
- Wu, J., et al. (2021). Thymosin Alpha-1 Therapy and Postoperative Survival. Int J Cancer, 148(5).
- King, R., et al. (2016). Immune Modulation with Thymosin Alpha 1 Treatment. Vitamins & Hormones, 102.
- Romani, L., et al. (2024). Phenotypic Drug Discovery: A Case for Thymosin Alpha 1. Front Med, 11.